Bringing scientists and clinicians closer together is one way to improve the success of phase II clinical trials of novel childhood cancer therapies. An Australian study examining the influence of 24 preclinical and trial design variables on the success of 132 paediatric oncology trials found no evidence that the conduct of any preclinical experiments made ...
Predicting success in kids’ cancer trials
By Mardi Chapman
6 Mar 2019